Cosmomed Expands Its Medical Device and OTC Portfolio Through Exclusive Partnership with Nova Argentia
Cosmomed S.A., a leading provider of medical devices and OTC healthcare products, has signed an exclusive distribution agreement with Industria Farmaceutica Nova Argentia, a renowned Italian pharmaceutical company with a legacy dating back to 1947. This agreement strengthens the decade-long strategic collaboration between the two companies and introduces five innovative medical device solutions to the Greek market.
Nova Argentia is recognized for its high-quality, clinically tested healthcare products, fully compliant with the strictest European regulatory standards. With a strong focus on safety, efficacy, and innovation, the company implements advanced manufacturing and quality control procedures, delivering trusted solutions for both healthcare professionals and consumers.
New Products for the Greek Market
Under this agreement, Cosmomed will distribute the following innovative medical devices:
-
NOVA H – A specialized gel for the relief of hemorrhoids, available in convenient single-dose tubes.
-
PUNTUALE MICRO PROPOLAX (Adults & Children) – Micro-enemas featuring Propolax®, a patented formula for fast and effective relief.
-
NOVA 1947 MICRO BB (Children) – Glycerin-based micro-enemas specially formulated for children’s intestinal care.
-
NOVA EMOSTOP – An advanced hemostatic dressing using patented Novaclot® technology, stops bleeding within seconds. In 2023, NOVA EMOSTOP received the "Tech Fast" award from the European Union for its contribution to medical innovation.
All products will be distributed nationwide via leading pharmaceutical wholesalers, ensuring wide accessibility across pharmacies in Greece.
Strengthening a Decade-Long Partnership
"Cosmomed and Nova Argentia have been working closely for over a decade, and this new exclusive agreement further strengthens our strategic partnership," said Petros Zavakopoulos, CEO of Cosmomed. "By selecting these clinically validated medical devices, we are enhancing our portfolio with innovative and effective solutions for the Greek healthcare market. We look forward to expanding this collaboration in the coming years."
Looking Ahead: Growth in the Medical Device and OTC Sectors
The two companies are already exploring new opportunities to expand their medical device offerings in Greece. This initiative aims to boost Cosmomed’s presence in the rapidly growing medical device and OTC sector, delivering scientifically backed, high-quality solutions for everyday health needs.
This partnership confirms Cosmomed’s continued commitment to providing innovative health solutions and improving access to reliable medical and OTC products in Greece and beyond.